Taxamairin B is a potent anti-inflammatory agent; it reduces the expression of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) and the production of NO and ROS in LPS-induced RAW264.7 cells; it exhibits significant protective effects against LPS-induced acute lung injury in mice.